Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Xenios and LEUKOCARE Announce Strategic Partnership

Published: Thursday, October 03, 2013
Last Updated: Thursday, October 03, 2013
Bookmark and Share
LEUKOCARE grants exclusive license on its innovative inflammation inhibition technology and develops a generic coating to be commercialized by Xenios in various extracorporeal therapy systems.

Xenios AG and LEUKOCARE AG, two German based life science companies, have announced a strategic alliance for the development and marketing of Xenios’ extracorporeal support systems with LEUKOCARE’s anti-inflammatory surface coating.

LEUKOCARE has granted to Xenios a worldwide license of its relevant patents and know-how with exclusivity for anti-inflammatory surfaces.

Moreover, Xenios has assigned LEUKOCARE with the adaptation of the clinically proven coating technology to Xenios’ broad range of medical devices that will be commercialized under Novalung, Medos and further Xenios brands.

Anti-inflammatory coatings in Xenios’ medical devices aim to limit unwanted inflammatory responses generated by the artificial device materials to enable improved clinical outcome.

This innovative approach will be facilitated by LEUKOCARE’s proprietary Stabilizing and Protecting Solutions (SPS); these technologies represent a breakthrough in the development of biofunctional surfaces by stabilizing employed proteins, hence allowing terminal sterilization of these combination devices. This results in a higher level of product quality with significantly reduced manufacturing costs compared to aseptic production.

“With LEUKOCARE we have an innovative and ideal strategic partner to develop significantly improved medical devices. The anti-inflammatory function will allow for next generation extracorporeal devices offering tremendous improvement in all kinds of therapies conducting blood outside the human body.” said Josef Bogenschütz, CEO of Xenios.

"There is an urgent medical need to reduce inflammation in patients undergoing cardiac surgery or depending on support for a diseased lung to achieve our goal of better clinical outcomes for physicians and of course for their patients." Dr. Jürgen O. Böhm, CMMO with Xenios added.

Michael Scholl, CEO of LEUKOCARE, said: “Xenios is a strong partner: its pertinent expertise in the respective markets of extracorporeal devices and the broad range of products that will benefit from the anti-inflammatory surfaces make Xenios the perfect match for our company. This collaborative project demonstrates the full range of LEUKOCARE’s capabilities from evaluating biologically active compounds to developing marketable applications and integrating them into industrial scale processes.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More Than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

LEUKOCARE Announces EUR 3.4 M Capital Increase
Fundraising ensures further execution of license-based business model.
Tuesday, September 03, 2013
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Scientists Find Evidence That Cancer Can Arise Changes
Researchers at Rockefeller University have found a mutation that affects the proteins that package DNA without changing the DNA itself can cause a rare form of cancer.
Developing a More Precise Seasonal Flu Vaccine
During the 2014-15 flu season, the poor match between the virus used to make the world’s vaccine stocks and the circulating seasonal virus yielded a vaccine that was less than 20 percent effective.
A Peachy Defense System for Seeds
ETH chemists are developing a new coating method to protect seeds from being eaten by insects. In doing so, they have drawn inspiration from the humble peach and a few of its peers.
Fighting Cancer with Borrowed Immunity
A new step in cancer immunotherapy: researchers from the Netherlands Cancer Institute and University of Oslo/Oslo University Hospital show that even if one's own immune cells cannot recognize and fight their tumors, someone else's immune cells might.
Modified Microalgae Converts Sunlight into Valuable Medicine
A special type of microalgae can soon produce valuable chemicals such as cancer treatment drugs and much more just by harnessing energy from the sun.
Breakthrough Approach to Breast Cancer Treatment
Scripps scientists have designed a drug candidate that decreases growth of breast cancer cells.
Loss Of Y Chromosome Increases Risk Of Alzheimer’s
Men with blood cells that do not carry the Y chromosome are at greater risk of being diagnosed with Alzheimer’s disease. This is in addition to an increased risk of death from other causes, including many cancers. These new findings by researchers at Uppsala University could lead to a simple test to identify those at risk of developing Alzheimer’s disease.
Making Virus Sensors Cheap and Simple
Researchers at The University of Texas at Austin demonstrated the ability to detect single viruses in a solution containing murine cytomegalovirus (MCMV).
A Guide to CRISPR Gene Activation
A comparison of synthetic gene-activating Cas9 proteins can help guide research and development of therapeutic approaches.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!